Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01376622 · ClinicalTrials.gov registry record
Changes in Pituitary Iron and Volume With Deferasirox
A clinical trial of Iron Overload, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT01376622 is a study of Iron Overload that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 130 participants, below the 290-participant average among 5 other Iron Overload trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01376622, a study of Iron Overload, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite continuing advances in iron chelation therapy, iron toxicity of endocrine glands, particularly the pituitary gland, remains common in patients with transfusion dependent anemias. We would like to establish accurate population norms of pituitary R2 and volume and understand the progression of pituitary iron in transfused patients on Deferasirox.
Conditions Studied
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01376622
The ClinicalTrials.gov registry entry for NCT01376622 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 290-participant average among 5 other Iron Overload trials with a reported enrollment target (55% lower). The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Iron Overload appearing as the primary indexed condition, and to 0 interventions.
NCT01376622 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01376622 about?
NCT01376622 is a clinical study titled "Changes in Pituitary Iron and Volume With Deferasirox". Despite continuing advances in iron chelation therapy, iron toxicity of endocrine glands, particularly the pituitary gland, remains common in patients with transfusion dependent anemias. We would like to establish accurate population norms of pituitary R2 and volume and understand the progression of...
What is the current status of trial NCT01376622?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2008-11. Estimated completion is 2011-07-01.
What conditions does trial NCT01376622 study?
This clinical trial studies the following conditions: Iron Overload.
Who is sponsoring clinical trial NCT01376622?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01376622 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron Overload
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fully Automated High-Throughput Quantitative MRI of the Liver
RECRUITING
-
Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption
RECRUITING
-
Ethnic Differences in Iron Absorption (FeGenes)
ACTIVE NOT RECRUITING
-
Combination Iron Chelation Therapy
COMPLETED · Phase 1
-
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
COMPLETED · NA
-
Iron Overload in African Americans
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.